(4-014) Real-world Risk of Medullary Thyroid Carcinoma with GLP-1 Receptor Agonist Use: A Review

Monday, December 5, 2022

2:00 PM – 3:30 PM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Clinical Topics/Therapeutics

Co-Author(s): Eric Dietrich

Primary Author(s)

Andrew S. Tenpas, PharmD
Clinical Assistant Professor
Texas A&M Irma Lerma Rangel School of Pharmacy, Texas